Table 2 Results from the unconditional Latent Growth Curve analysis

Pain

4.48 (1.41)

<.001

−0.6 (0.44)

<.001

0.03 (0.03)

<.001

Medication Usage > 0

5.13 (3.78)

<.001

−0.83 (1.02)

<.001

0.04 (0.05)

<.001

Medication Usage (all)

2.10 (3.65)

<.001

−0.14 (0.85)

0.092

0.003 (0.03)

0.599

Surgery Intent > 0

18.52 (15.44)

<.001

−3.36 (4.08)

<.001

0.20 (0.35)

0.001

Surgery Intent (all)

5.82 (10.98)

<.001

−0.95 (2.54)

<.001

0.06 (0.20)

0.002

GAD ≥5

9.30 (3.77)

<.001

−1.14 (0.86)

<.001

0.06 (0.03)

<.001

GAD (all)

2.81 (3.48)

<.001

−0.26 (0.62)

<.001

0.01 (0.03)

<.001

PHQ ≥5

9.69 (4.66)

<.001

−1.31 (1.14)

<.001

0.07 (0.06)

<.001

PHQ (all)

2.40 (3.26)

<.001

−0.17 (0.66)

<.001

0.007 (0.04)

0.049

FABQ

10.91 (4.59)

<.001

−0.72 (0.85)

<.001

0.03 (0.05)

<.001

WPAI Overall > 0

23.55 (11.63)

<.001

−3.71 (3.65)

<.001

0.18 (0.22)

<.001

WPAI Overall (all)

10.89 (13.05)

<.001

−1.15 (3.09)

<.001

0.04 (0.17)

0.044

WPAI Work Impairment > 0

22.41 (10.84)

<.001

−3.44 (3.34)

<.001

0.16 (0.20)

<.001

WPAI Work Impairment (all)

10.23 (11.86)

<.001

−1.03 (2.90)

<.001

0.04 (0.14)

0.078

WPAI Activity Impairment > 0

28.20 (9.18)

<.001

−3.67 (2.99)

<.001

0.16 (0.22)

<.001

WPAI Activity Impairment (all)

21.56 (13.08)

<.001

−2.50 (2.89)

<.001

0.10 (0.20)

<.001